Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
February 20, 2024 04:00 ET
|
AKAMPION
- Designation underlines the need for novel, first-in-class antimicrobials for the treatment of infections with Gram-negative bacteria JERUSALEM, Israel, February 20, 2023 -- Omnix Medical, a...
Metronidazole Market Forecast to 2032: Highlights Trends and the Competitive Landscape in CDI Treatment
January 30, 2024 06:44 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This insightful report provides...
Vancomycin Drug Insights and Market Forecast to 2032 for Clostridium Difficile Infection Treatment in Key Global Regions
January 29, 2024 12:38 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
Global Antibacterial Drugs Market Projected to Exceed $39 Billion by 2024 Amidst Challenges and Innovations
January 25, 2024 10:40 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Antibacterial Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for the antibacterial drugs market...
Glycopeptide Antibiotics Global Market Report 2024: Forecast to Reach $5.02 Billion by 2028 - Long-term Forecast to 2028 and 2033
January 25, 2024 04:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
ZINPLAVA (Bezlotoxumab) Drug Insight and Market Forecasts, 2019-2032: Developed by Merck Sharp & Dohme, A Human Monoclonal Antibody that Binds to C
January 24, 2024 08:17 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ZINPLAVA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture...
DIFICID (Fidaxomicin) Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Macrolide Antibiotic Used to Treat CDAD - Focus on United States, Germany, France, Italy, Spain, UK, and Japan
January 24, 2024 08:16 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DIFICID Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed picture of...
With 2.5% CAGR, Global Antibiotics Market Size, Share & Growth Analysis, [2028]
December 13, 2023 06:44 ET
|
Fortune Business Insights
Pune, India, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Global Antibiotics Market Size was valued at USD 37.35 billion in 2020 and is projected to grow USD 45.30 billion by 2028 exhibiting a CAGR of 2.5%...
Microbial Fermentation Technology Market revenue to hit USD 63 Billion by 2036, says Research Nester
December 06, 2023 06:00 ET
|
Research Nester
New York , Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global microbial fermentation technology market size is expected to expand at 6% CAGR from 2024 to 2036. The market is anticipated to garner a...
Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)
November 24, 2023 08:00 ET
|
Er-Kim Pharmaceuticals
Er-Kim Pharmaceuticals joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week